Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Novartis
Moodys
Harvard Business School
Covington
US Army
Boehringer Ingelheim
Daiichi Sankyo
Teva
Cerilliant
Farmers Insurance

Generated: February 25, 2018

DrugPatentWatch Database Preview

Details for Patent: 5,916,893

« Back to Dashboard

Summary for Patent: 5,916,893
Title: Treatment of a latent infection of herpes virus
Abstract:A method for the treatment of latent infection of herpesviruses in mammals, including humans, which method comprises administering to the mammal in need of such treatment, an effective amount of a compound of formula (A): ##STR1## or a bioprecursor, or a pharmaceutically acceptable salt, phosphate ester and/or acyl derivative of either of the foregoing.
Inventor(s): Field; Hugh John (Cambridge, GB), Thackray; Alana Maureen (Cambridge, GB), Bacon; Teresa Helen (Epsom, GB), Sutton; David (Phoenixville, PA), Vere Hodge; Richard Anthony (Reigate, GB)
Assignee: SmithKline Beecham p.l.c. (Brentford, GB)
Application Number:08/845,720
Patent Claim Types:
see list of patent claims
Use;

Drugs Protected by US Patent 5,916,893

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Patent Submitted
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Patent Submitted

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

Foreign Priority and PCT Information for Patent: 5,916,893

Foriegn Application Priority Data
Foreign Country Foreign Patent Number Foreign Patent Date
United Kingdom9425012Dec 12, 1994
United Kingdom9506663Mar 31, 1995
United Kingdom9517308Aug 24, 1995

International Patents Family Members for US Patent 5,916,893

Country Document Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration
Cyprus 2339 ➤ Sign Up
Czech Republic 9701799 ➤ Sign Up
Czech Republic 291545 ➤ Sign Up
Germany 69523776 ➤ Sign Up
Denmark 0799039 ➤ Sign Up
European Patent Office 0799039 ➤ Sign Up
Hong Kong 1003259 ➤ Sign Up
Spain 2166834 ➤ Sign Up
United Kingdom 9425012 ➤ Sign Up
United Kingdom 9506663 ➤ Sign Up
Country Document Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Cantor Fitzgerald
McKinsey
Accenture
Deloitte
Farmers Insurance
Johnson and Johnson
QuintilesIMS
Moodys
UBS

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

botpot